Skip to main content
. 2024 Sep 16;15:73. doi: 10.1186/s13293-024-00648-6

Table 1.

Clinical characteristics of patients in our cohort

Patients, n(%) Trios/duos, n Singletons, n
Age 3.5 ± 3(Years)
Minipubertal age (< 6 months) 54 26 28
Prepubertal age (6 months-9 years) 294 164 130
Pubertal age (9–18 years) 54 27 27
total 402 217 185
Ethnicity
Han 395(98.3%)
Others 7(1.7%)
Clinical diagnosis
Gonadal dysgenesis(GD) 10(2.5%) 2 8
5α-reductase 2 defciency 6(1.5%) 5 1
Androgen insensitivity(AIS) 3(0.7%) 0 3
46 XY, DSD of clinically unknown etiology
Hypospadias 91(22.5%) 52 39
Hypospadias, Micropenis 4(1.2%) 1 3
Hypospadias, Cryptorchidism 6(1.5%) 1 5
Cryptorchidism(bilateral) 12(2.9%) 6 6
Cryptorchidism(right or left ) 20(5.1%) 10 10
Cryptorchidism, Micropenis 12(2.9%) 6 6
Micropenis 205(50.6%) 120 85
Ambiguous genitalia 2(0.5%) 0 2
Ambiguous genitalia, Hypospadias 5(1.5%) 2 3
Hypospadias, gonadal dysgenesis 3(0.7%) 0 3
CHD with DSD-related phenotype 10(2.4%) 7 3
Growth retardation with DSD-related phenotype 3(0.7%) 1 2
Hypospadias with other malformations 6(1.5%) 2 4
Micropenis with other malformations 3(0.7%) 2 1
Cryptorchidism with other malformations 1(0.2%) 0 1
total 402 217 185

Note The diagnostic rate for each phenotype was calculated by dividing the number of positive samples by the total number of patients with that phenotype